During the past decade, Clinical Research Consultants,LLC conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 15 clinical trials were completed, i.e. on average, 57.7% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 7 clinical trials were completed. i.e. 36.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Consultants,LLC" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Bayer" with 3 trials sponsored, "Goldfinch Bio, Inc." with 3 trials sponsored and "Reata Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Consultants,LLC" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Centessa Pharmaceuticals plc" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Consultants,LLC" are "Autosomal Dominant Polycystic Kidney" (4 trials), "Chronic Kidney Disease" (4 trials), "Chronic Kidney Diseases" (3 trials), "Diabetic Nephropathies" (3 trials) and "Hyperkalemia" (3 trials). Many other conditions were trialed in "Clinical Research Consultants,LLC" in a lesser frequency.

Most popular intervention types in "Clinical Research Consultants,LLC" are "Drug" (28 trials), "Other" (4 trials), "Biological" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Empagliflozin" (4 trials), "Finerenone (BAY94-8862)" (2 trials), "GFB-887" (2 trials) and "Participating Site's standard practice" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Consultants,LLC" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Consultants,LLC". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Clinical Research Consultants,LLC, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Consultants,LLC, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".